As part of the largest interventional canine clinical trial ever conducted, veterinarians leading the Vaccine Against Canine Cancer Study seek to enroll 800 healthy, middle-aged pet dogs to evaluate the effectiveness of a new cancer prevention vaccine.
The goal of the VACCS trial is to evaluate a new vaccine strategy for the prevention, rather than treatment of dogs with cancer. Healthy dogs of certain breeds, 6 years or older, will be randomized to receive either a series of vaccines similar to other routine vaccines that are given to dogs currently, or placebo vaccines. Dogs will live at home and be checked 2-3 times yearly for 5 years after enrollment.
In addition to potentially providing a new strategy for cancer prevention in dogs, if successful, this study could provide important justification for eventually looking at a similar approach in humans.
For further information check out the following resources:
Check out the Oncology category
on Vetlexicon Canis
for more information on canine cancer. Amongst others, topics include:
Image: Myeloma: thorax - radiograph lateral ©University of Cambridge